Tmmune AG

Transimmune AG is developing novel immunotherapies based on its unique understanding of the physiologic processes underlying the activation of antigen presenting cells. This understanding derives from nearly 30 years of research into the mechanism of action behind Extracorporeal Photopheresis (ECP), arguably the first FDA-approved cellular immunotherapy.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://transimmune.com
Founded2017
Disease Focus
Development Stage
STOCK CODENon Listed
Address
Konigsallee 90, 40212
Dusseldorf
Germany
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]